4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-22-004427
Options or other derivatives
- CFO and Chief Business Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Zuga Matt CFO and Chief Business Officer | 2022-01-19 | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/doc4.xml…